Company Information

Mission & Vision

MISSION

We aspire to stay vibrant and actively connected to society, for all time. We want our loved ones to live long,healthy lives, enduring through time.To fulfill this lifelong aspiration, we are committed to advancing the research and development of regenerative medicine.Our mission is to enable countless individuals to enjoy extended healthy lifespans, empowering them to lead vibrant and meaningful lives.

VISION

To support healthier and longer lives for more people, we strive to:Advance research to improve cultivation efficiency, Lower cultivation costs while ensuring safety, Make high-quality stem cell treatments more accessible, bringing advanced healthcare closer to society, for generations to come

Company Profile

Company NameCellastar Co., Ltd.
LocationKiswire Hatchobori Building Floor 6, 4-6-5, Hatchobori, Chuo-ku, Tokyo, 104-0032, JAPAN
TEL+81-3-6280-4282 (10:00-17:00)
FAX+81-3-6280-5262
EstablishedMarch 6, 2023
LicensePermit for Specified Cell Processing (Facility No: FA3240005)
Business DescriptionRegenerative Medicine Related Business
RepresentativeShigeo Murakami
ExecutivesPresident & CEO: Shigeo Murakami
Director: Mitsunori Suwa
Director: Ryoji Ota
Auditor: Keisuke Yoshida
Capital¥113,456,000
URLhttps://cellastar.co.jp/

History

05/2013Enactment and enforcement of the Regenerative Medicine Promotion Act
01/2014Enforcement of the Act on the Safety of Regenerative Medicine and the Pharmaceuticals and Medical Devices Act in Japan
01/2019Establishment of Cerustar
10/2019Started joint research with A*STAR (Agency for Science, Technology and Research, Singapore) on efficient culture methods for adipose-derived cells
04/2021Discovered AGA suppression and antibacterial effects in culture supernatant as a result of A*STAR research
03/2023Establishment of Cellastar Co., Ltd.
10/2024Completion of Cellastar CPF (Cell Processing Facility)
12/2024Cellastar CPF obtained permit for specified cell processing (Facility No: FA324005)